Restructuring, consolidation in health care make reform top US health law issue for 2010

11 January 2010

Health care reform in the USA will change, if not send shock waves through, virtually the entire field of health care law. That is the consensus of 24 health law practitioners from BNA's Health Law Reporter advisory board, in a survey conducted in December 2009.

The majority of survey respondents applauded reform's major goals: increasing access to needed health care services, promoting provider coordination and integration, supporting a stronger role for primary care and improving care for people with chronic conditions or complex needs, holding providers more accountable for results, and increasing health system efficiencies. They debated, however, whether current reform initiatives would bring these changes about, or whether congressional proposals will just create more problems down the road.

Rounding out the top half of the Top 10 list were: Fraud and abuse, Medicare, quality, and antitrust. These key issues are followed by health information, taxation, health plan regulation, medical staff, and labor and employment as front-burner concerns with which the health care system will be dealing in 2010. All survey respondents agreed that health care reform will be an issue with reverberations throughout all of the others.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical